ADAMI, Roger Christopher,DAVID, Frederick Pfizer Global R & D,WOOD, Julia Ann
申请号：
DK05702263
公开号：
DK1713504T3
申请日:
2005.01.17
申请国别(地区):
DK
年份:
2017
代理人:
摘要：
The present invention is directed to pharmaceutical compositions containing a therapeutically effective amount of an Active Pharmaceutical Ingredient (&ldquo；API&rdquo；), a pharmaceutically acceptable cyclodextrin and a pharmaceutically acceptable preservative. The invention is also directed to pharmaceutical compositions of the compounds of Formula (I) wherein R2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl and a pharmaceutically acceptable cyclodextrin and preservative. Formula (I): In particular, the invention is directed to pharmaceutical compositions of the compound of Formula 1a, and a pharmaceutically acceptable cyclodextrin and a preservative.
